I have to say upfront that I don't know anything more than you about this deal. I believe that multinationals, when dealing with small caps get exactly what they want.
That could mean a good deal for ABT if this one is greedy but ethical. or if greedy and unethical , just being diddled around until ABT burns all of their cash so what is on offer can be obtained in a fire sale.
Predicting revenues is like a lucky dip from what we have in ANNs.
Commercialisation was supposed to be over 2017 and 2018. No signs of any traction yet though.
Cucumbers tested with a global company in early 2016.
It took over a year after this to sign a deal (signed mid 2017).
Commercialisation 2017 and 2018 but revenues are very small to date. 4C receipts were low- under 10K for last 2 quarters.
It doesn't look good so far imo but it is too early to call. I think we will know a bit more in a year or two. Looks like will need a CR to get to that point though.
ABT Price at posting:
47.5¢ Sentiment: Sell Disclosure: Not Held
